🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/02/2018 | 97,07 | 99,69 | 96,70 | 97,53 | +0,53% | 3,08% | 338.233 |
| 20/02/2018 | 97,36 | 98,66 | 96,65 | 97,01 | -1,04% | 2,06% | 276.998 |
| 16/02/2018 | 97,70 | 99,43 | 97,03 | 98,03 | -0,03% | 2,46% | 230.511 |
| 15/02/2018 | 99,11 | 99,15 | 96,97 | 98,05 | -0,04% | 2,20% | 219.932 |
| 14/02/2018 | 94,38 | 98,57 | 92,48 | 98,10 | +3,09% | 6,46% | 369.652 |
| 13/02/2018 | 94,71 | 97,19 | 94,04 | 95,16 | +0,08% | 3,33% | 288.380 |
| 12/02/2018 | 94,04 | 95,93 | 93,33 | 95,08 | +1,57% | 2,77% | 263.854 |
| 09/02/2018 | 94,33 | 94,85 | 90,87 | 93,62 | +0,05% | 4,22% | 437.940 |
| 08/02/2018 | 96,46 | 97,52 | 93,57 | 93,57 | -2,45% | 4,09% | 460.382 |
| 07/02/2018 | 96,19 | 98,35 | 95,14 | 95,92 | -0,20% | 3,34% | 637.994 |
| 06/02/2018 | 93,98 | 96,61 | 93,61 | 96,11 | +0,90% | 3,20% | 628.216 |
| 05/02/2018 | 97,50 | 100,11 | 95,26 | 95,26 | -2,78% | 4,98% | 532.036 |
| 02/02/2018 | 98,85 | 99,88 | 97,90 | 97,99 | -1,71% | 2,01% | 358.431 |
| 01/02/2018 | 97,85 | 99,98 | 97,60 | 99,69 | +1,39% | 2,43% | 678.390 |
| 31/01/2018 | 103,39 | 103,39 | 98,02 | 98,33 | -4,39% | 5,19% | 654.184 |
| 30/01/2018 | 104,04 | 104,65 | 102,34 | 102,84 | -1,97% | 2,22% | 504.304 |
| 29/01/2018 | 104,24 | 106,24 | 103,56 | 104,91 | +1,40% | 2,57% | 849.911 |
| 26/01/2018 | 104,18 | 104,91 | 103,06 | 103,46 | -0,27% | 1,77% | 1.190.869 |
| 25/01/2018 | 102,18 | 104,17 | 100,51 | 103,74 | +1,53% | 3,59% | 363.080 |
| 24/01/2018 | 101,78 | 104,24 | 101,39 | 102,18 | +0,42% | 2,79% | 641.360 |
| 23/01/2018 | 100,13 | 102,73 | 100,12 | 101,75 | +2,20% | 2,60% | 698.267 |
| 22/01/2018 | 97,50 | 100,75 | 97,30 | 99,56 | +2,43% | 3,54% | 765.112 |
| 19/01/2018 | 94,08 | 97,50 | 94,08 | 97,20 | +3,49% | 3,64% | 804.225 |
| 18/01/2018 | 93,04 | 94,77 | 91,93 | 93,92 | +0,82% | 3,05% | 422.391 |
| 17/01/2018 | 91,98 | 93,45 | 91,33 | 93,16 | +2,01% | 2,31% | 416.940 |
| 16/01/2018 | 93,45 | 94,62 | 91,27 | 91,32 | -1,69% | 3,58% | 301.845 |
| 12/01/2018 | 92,40 | 93,10 | 92,13 | 92,89 | +0,64% | 1,05% | 266.739 |
| 11/01/2018 | 91,31 | 92,61 | 90,53 | 92,30 | +1,22% | 2,28% | 284.052 |
| 10/01/2018 | 89,76 | 91,57 | 88,09 | 91,19 | +1,33% | 3,88% | 225.863 |
| 09/01/2018 | 88,28 | 90,35 | 87,78 | 89,99 | +2,21% | 2,91% | 524.662 |